New User:

-or-
Username:
Password:
Forgot your password?

Stock Market & Financial Investment News

News Breaks
September 19, 2012
12:12 EDTQCORQuestcor weakness a buying opportunity, says Leerink
Leerink said Questcor's (QCOR) Acthar sales are still seeing rising prescriptions and that the Aetna news does not appear to be new. The firm confirmed with Aetna (AET) that Acthar is reimbursed as a second tier drug.
News For QCOR From The Last 14 Days
Sign up for a free trial to see the rest of the stories you've been missing.
There are no results for QCOR

Sign up for a free trial to see the rest of the stories you've been missing.

I agree to the theflyonthewall.com disclaimer & terms of use